DK0654042T3 - Amylinmuteiner - Google Patents

Amylinmuteiner

Info

Publication number
DK0654042T3
DK0654042T3 DK93911125T DK93911125T DK0654042T3 DK 0654042 T3 DK0654042 T3 DK 0654042T3 DK 93911125 T DK93911125 T DK 93911125T DK 93911125 T DK93911125 T DK 93911125T DK 0654042 T3 DK0654042 T3 DK 0654042T3
Authority
DK
Denmark
Prior art keywords
insulin action
muteins
muscle
suppressing
amylin
Prior art date
Application number
DK93911125T
Other languages
English (en)
Inventor
Glenn Colton Andrews
David Kevin Kreutter
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0654042T3 publication Critical patent/DK0654042T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93911125T 1992-08-06 1993-05-12 Amylinmuteiner DK0654042T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92678392A 1992-08-06 1992-08-06
PCT/US1993/004314 WO1994003491A1 (en) 1992-08-06 1993-05-12 Amylin muteins

Publications (1)

Publication Number Publication Date
DK0654042T3 true DK0654042T3 (da) 1999-02-15

Family

ID=25453715

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93911125T DK0654042T3 (da) 1992-08-06 1993-05-12 Amylinmuteiner

Country Status (9)

Country Link
EP (1) EP0654042B1 (da)
JP (1) JPH07506114A (da)
AT (1) ATE171951T1 (da)
CA (1) CA2141203C (da)
DE (1) DE69321473T2 (da)
DK (1) DK0654042T3 (da)
ES (1) ES2122010T3 (da)
FI (1) FI933476A (da)
WO (1) WO1994003491A1 (da)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
WO1989006135A1 (en) * 1988-01-11 1989-07-13 Amylin Corporation Treatment of type 2 diabetes mellitus

Also Published As

Publication number Publication date
EP0654042A1 (en) 1995-05-24
FI933476A0 (fi) 1993-08-05
ES2122010T3 (es) 1998-12-16
DE69321473D1 (en) 1998-11-12
DE69321473T2 (de) 1999-03-04
CA2141203C (en) 2003-07-08
WO1994003491A1 (en) 1994-02-17
CA2141203A1 (en) 1994-02-17
EP0654042B1 (en) 1998-10-07
FI933476A (fi) 1994-02-07
JPH07506114A (ja) 1995-07-06
ATE171951T1 (de) 1998-10-15

Similar Documents

Publication Publication Date Title
KR930003912A (ko) 울혈성 심장 마비 치료법
SE8502950L (sv) Ny galenisk retardform
EA199800943A1 (ru) Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы
DE69428125D1 (de) Fungizide tetrahydrofurane
ES2060910T3 (es) Peptidos que tienen actividad antagonista de taquiquinina, un procedimiento para su preparacion y composiciones farmaceuticas que los comprenden.
ES8801643A1 (es) Un metodo para producir nuevos derivados del acido ascorbico
IT8123602A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
RU92016453A (ru) Гидроксамовые кислоты и n-гидроксимочевины, способы их получения, фармацевтическая композиция и способ ингибирования липоксигеназы
ATE84045T1 (de) Hemmungsstoffe enkephalinase-b deren herstellung und deren pharmazeutische zusammensetzungen.
DK166323C (da) Griseolsyrederivater og farmaceutiske midler indeholdende disse
IT8123603A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
KR890014480A (ko) 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
KR910004557A (ko) 2,4,6-치환 페놀 유도체
DK0654042T3 (da) Amylinmuteiner
ATE50248T1 (de) Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung.
DK1058544T3 (da) Inhibition af TNF-aktivitet med præparater, der omfatter heparin og oplöselige TNF-receptorer
EP0339878A3 (en) Propanamine derivatives
FI884838A0 (fi) Nytt s-timololderivat och foerfarande foer dess framstaellning.
ES2038612T3 (es) Compuestos de hidroquinolina, composiciones que los contienen y procedimientos para prepararlas.
IT1168389B (it) Derivati di alcandioli con attivita' ipolipidemizzante,metodi per la loro preparazione e composizioni farmaceutiche che li contengono
SE8702422D0 (sv) Improvements in or relating to fungicides
IT1215340B (it) Derivati di esteri dell'acido immidazol-1-il-carbossilico, procedimenti per la loro preparazione e composizioni fungicide che contengono il derivato come componente attivo.
EA199800146A1 (ru) Использование иприфлавона для понижения числа cd8+ клеток